Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-10-13

FDA Approved: NATEGLINIDE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approves a supplemental application for nateglinide by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nateglinide (nateglinide)

Snippet

SUPPL AP for NATEGLINIDE (NATEGLINIDE)